DURHAM, N.C. & SEATTLE--January 12, 2025--Leading epigenome editing company Tune Therapeutics (Tune) today announced the completion of over $175M in financing led by New Enterprise Associates, Yosemite, Regeneron Ventures and...
Eric Linsley to join panel at the MedTech Investing Conference in Minneapolis, MN
News | 05. 10. 2006
